The tumour microenvironment plays an essential role in tumour growth and progression. The tumour microenvironment is composed of different cell types, including macrophages, fibroblasts, various inflammatory cells, fat cells and endothelial cells, collectively known as stroma. Most recent studies believe that the tumour microenvironment in many solid tumours including breast cancer defines outcome in oestrogen receptor positive (ER+) and triple negative breast cancer (TNBC). This PhD project was established in order to test the hypothesis that cells within the tumour microenvironment influence breast cancer outcome and this differs in ER+ versus TNBC disease. As part of the project, 7 biomarkers were used to identify stromal cells includi...
Triple negative breast cancer (TNBC) is characterized by cells lacking estrogen receptor (ER), proge...
BACKGROUND: The importance of the components of host local inflammatory response in determining outc...
Background: Breast ductal carcinoma in situ (DCIS) accounts for more than 20% of screen-detected br...
Triple-Negative Breast Cancer (TNBC) is defined by the lack of immunohistochemical expression in bot...
Immune response which involves distinct immune cells is associated with prognosis of breast cancer. ...
Purpose: The purpose and aim of this project was to investigate immune contexture according to tumou...
Background: Cancer research was focused on the studying of proper tumor cells for a long time. Despi...
INTRODUCTION: An emerging hypothesis suggests that cytokines could play an important role in cancer ...
Although global gene microarray studies have demonstrated the molecular heterogeneity of breast canc...
BACKGROUND: T-cell infiltration in estrogen receptor (ER)-negative breast tumours has been associate...
$\textbf{Background}$: Immune infiltration of breast tumours is associated with clinical outcome. Ho...
Tumor heterogeneity may broadly influence the activation of tumor-associated macrophages. We aimed t...
Background: Cancer-associated fibroblasts (CAFs) are the most abundant cell type in the tumor microe...
Purpose: Extensive work in preclinical models has shown that microenvironmental cells influence many...
Purpose: Extensive work in preclinical models has shown that microenvironmental cells influence many...
Triple negative breast cancer (TNBC) is characterized by cells lacking estrogen receptor (ER), proge...
BACKGROUND: The importance of the components of host local inflammatory response in determining outc...
Background: Breast ductal carcinoma in situ (DCIS) accounts for more than 20% of screen-detected br...
Triple-Negative Breast Cancer (TNBC) is defined by the lack of immunohistochemical expression in bot...
Immune response which involves distinct immune cells is associated with prognosis of breast cancer. ...
Purpose: The purpose and aim of this project was to investigate immune contexture according to tumou...
Background: Cancer research was focused on the studying of proper tumor cells for a long time. Despi...
INTRODUCTION: An emerging hypothesis suggests that cytokines could play an important role in cancer ...
Although global gene microarray studies have demonstrated the molecular heterogeneity of breast canc...
BACKGROUND: T-cell infiltration in estrogen receptor (ER)-negative breast tumours has been associate...
$\textbf{Background}$: Immune infiltration of breast tumours is associated with clinical outcome. Ho...
Tumor heterogeneity may broadly influence the activation of tumor-associated macrophages. We aimed t...
Background: Cancer-associated fibroblasts (CAFs) are the most abundant cell type in the tumor microe...
Purpose: Extensive work in preclinical models has shown that microenvironmental cells influence many...
Purpose: Extensive work in preclinical models has shown that microenvironmental cells influence many...
Triple negative breast cancer (TNBC) is characterized by cells lacking estrogen receptor (ER), proge...
BACKGROUND: The importance of the components of host local inflammatory response in determining outc...
Background: Breast ductal carcinoma in situ (DCIS) accounts for more than 20% of screen-detected br...